✦ LIBER ✦

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01 E Malaria Candidate Vaccine When Integrated in the Expanded Program of Immunization

✍ Scribed by Agnandji, Selidji T.; Asante, Kwaku Poku; Lyimo, John; Vekemans, Johan; Soulanoudjingar, Solange S.; Owusu, Ruth; Shomari, Mwanajaa; Leach, Amanda; Fernandes, Jose; Dosoo, David; Chikawe, Maria; Issifou, Saadou; Osei‐Kwakye, Kingsley; Lievens, Marc; Paricek, Maria; Apanga, Stephen; Mwangoka, Grace; Okissi, Blaise; Kwara, Evans; Minja, Rose; Lange, Jorn; Boahen, Owusu; Kayan, Kingsley; Adjei, George; Chandramohan, Daniel; Jongert, Erik; Demoitié, Marie‐Ange; Dubois, Marie‐Claude; Carter, Terrel; Vansadia, Preeti; Villafana, Tonya; Sillman, Marla; Savarese, Barbara; Lapierre, Didier; Ballou, William Ripley; Greenwood, Brian; Tanner, Marcel; Cohen, Joe; Kremsner, Peter G.; Lell, Bertrand; Owusu‐Agyei, Seth; Abdulla, Salim

Book ID: 121756845
Publisher: University of Chicago Press
Year: 2010
Tongue: English
Weight: 677 KB
Volume: 202
Category: Article
ISSN: 0022-1899
DOI: 10.1086/656190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of the RTS,S/A

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique

✍ E. Macete; J. J. Aponte; C. Guinovart; J. Sacarlal; O. Ofori-Anyinam; I. Mandoma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 535 KB

Safety and efficacy of the RTS,S/AS01E c

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

✍ Kwaku Poku Asante; Salim Abdulla; Selidji Agnandji; John Lyimo; Johan Vekemans; 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 260 KB

Pre-clinical evaluation of new adjuvant

Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A

✍ V. Ann Stewart; Shannon M. McGrath; Douglas S. Walsh; Stacey Davis; Aaron S. Hes 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 873 KB

Safety and immunogenicity of the malaria

Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon

✍ Benjamin Mordmüller; Katja Szywon; Benedikt Greutelaers; Meral Esen; Ludovic Mew 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 243 KB

A phase I/IIa safety, immunogenicity, an

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

✍ Kent E. Kester; Denise A. McKinney; Nadia Tornieporth; Christian F. Ockenhouse; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Randomized, controlled trial of the long

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02Dmalaria vaccine in infants living in a malaria-endemic region

✍ Salim Abdulla, Nahya Salim, Francisca Machera, Richard Kamata, Omar Juma… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 243 KB